{
  "created_at": "Sat Jul 03 22:30:50 +0000 2021",
  "id_str": "1411376757379321857",
  "full_text": "Bharat Biotech, of India, said its Covid-19 vaccine was effective against the coronavirus and provided significant protection against the Delta variant in late-stage clinical trials https://t.co/mTFbaqKMeD",
  "display_text_range": [
    0,
    205
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/mTFbaqKMeD",
        "expanded_url": "https://on.wsj.com/36ak779",
        "display_url": "on.wsj.com/36ak779",
        "indices": [
          182,
          205
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 29,
  "favorite_count": 93,
  "possibly_sensitive": false,
  "original_created_at": "Sat Jul 03 17:30:15 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "インドのBharat Biotech社は、同社のCovid-19ワクチンがコロナウイルスに対して有効であり、後期の臨床試験ではDeltaバリアントに対して有意な防御効果を示したと発表した。https://t.co/mTFbaqKMeD"
    },
    {
      "locale": "zh",
      "full_text": "印度的Bharat Biotech公司表示，其Covid-19疫苗对冠状病毒有效，并在后期临床试验中对Delta变体提供了显著保护https://t.co/mTFbaqKMeD。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "印度的Bharat Biotech公司表示，其Covid-19疫苗對冠狀病毒有效，並在後期臨牀試驗中對Delta變體提供了顯著保護https://t.co/mTFbaqKMeD。"
    }
  ]
}